Formulation and characterization of sustained released tablet of deflazacort for colon targeting

  • Shubhangi Patil Department of Pharmaceutics, Oriental College of Pharmacy & Research, Oriental University, Indore, Madhya Pradesh, India
  • Ankit Agrawal 2Department of Pharmaceutics, Chameli Devi Institute of Pharmacy, Indore, Madhya Pradesh, India
  • Gurdeep Singh Department of Pharmaceutics, Oriental College of Pharmacy & Research, Oriental University, Indore, Madhya Pradesh, India
  • M K Gupta Department of Pharmaceutics, Oriental College of Pharmacy & Research, Oriental University, Indore, Madhya Pradesh, India

Abstract

Deflazacort is a glucocorticoid used as an anti-inflammatory and immunosuppressant. Deflazacort are commonly Prescribed for the patient in disease condition such as Inflammatory Bowel Disease (IBD) ulcerative colitis (UC) and Crohn’s disease (CD). Delivery of drug substances to the ileo-colonic region may be an essential element of successful drug treatment (improved efficacy or reduced systemic toxicity) in topical treatment of the colon. The colon targeted drug delivery can also be used for effective treatment of diseases. This may improve efficacy of drug treatment, decrease in dose to be administered, improved drug utilization. It is a promising site for a drug which is unstable or poorly absorbed. Currently available formulation of deflazacort is conventional solid dosage form (6, 12, 18 & 30 mg tablets). Dosage form require frequent dose of administration due to its short half life of 1.1-1.9 hrs. So, present study is aimed to develop an colon targeted sustained release dosage form has been developed as these releases the drug slowly into the ileo- colonic region and maintain constant drug concentration  in the serum for longer period of time.


Keywords: Deflazacort, Colon Targeting, IBD, Crohn’s Disease

Downloads

Download data is not yet available.

Author Biographies

Shubhangi Patil, Department of Pharmaceutics, Oriental College of Pharmacy & Research, Oriental University, Indore, Madhya Pradesh, India

Department of Pharmaceutics, Oriental College of Pharmacy & Research, Oriental University, Indore, Madhya Pradesh, India

Ankit Agrawal, 2Department of Pharmaceutics, Chameli Devi Institute of Pharmacy, Indore, Madhya Pradesh, India

2Department of Pharmaceutics, Chameli Devi Institute of Pharmacy, Indore, Madhya Pradesh, India

Gurdeep Singh, Department of Pharmaceutics, Oriental College of Pharmacy & Research, Oriental University, Indore, Madhya Pradesh, India

Department of Pharmaceutics, Oriental College of Pharmacy & Research, Oriental University, Indore, Madhya Pradesh, India

M K Gupta, Department of Pharmaceutics, Oriental College of Pharmacy & Research, Oriental University, Indore, Madhya Pradesh, India

Department of Pharmaceutics, Oriental College of Pharmacy & Research, Oriental University, Indore, Madhya Pradesh, India

Statistics
78 Views | 47 Downloads
How to Cite
Patil, S., Agrawal, A., Singh, G., & Gupta, M. K. (2019). Formulation and characterization of sustained released tablet of deflazacort for colon targeting. Journal of Drug Delivery and Therapeutics, 8(6-A), 102-105. Retrieved from http://jddtonline.info/index.php/jddt/article/view/2296